http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939566-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6572ff5df928fd17340eb2a8cb6d8502
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-22
filingDate 2009-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34858f7d76768f35ae5073e988a3fd5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b5903c804c00d9afc1fbf3e659a8b87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c02db35430c2be4e50eee8f97bc66a7
publicationDate 2011-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7939566-B2
titleOfInvention Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
abstract Crystalline form III of the compound of formula (I): n ncharacterised by its powder X-ray diffraction diagram.n n Medicinal products containing the same which are useful in the treatment of melatoninergic disorders.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009069434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8067639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013063289-A1
priorityDate 2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1564202-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0447285-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127924375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226486930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82148
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129806556
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616

Total number of triples: 42.